Get the Stockscreener App
175.90
0.60%
-1.06
After Hours:
175.90
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc Stock (DGX) Forecast
The Quest Diagnostics Inc (DGX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $156.43, representing a -11.07% decrease from the current price of $175.90. The highest analyst price target is $166.47, and the lowest is $146.40.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DGX Price Target
Average 161.85
(-7.99% Downside)
Is Quest Diagnostics Inc (DGX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 56.73 | Neutral |
| STOCH(9,6) | 55.09 | Neutral |
| STOCHRSI(14) | 28.36 | Neutral |
| MACD(12,26) | 2.4022 | Buy |
| ADX(14) | 20.04 | Neutral |
| William %R | -33.96 | Neutral |
| CCI(14) | -11.12 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
177.10
Sell
|
175.95
Sell
|
| MA20 |
173.45
Buy
|
174.08
Buy
|
| MA50 |
170.49
Buy
|
170.60
Buy
|
| MA100 |
164.92
Buy
|
166.47
Buy
|
| MA200 |
159.49
Buy
|
159.10
Buy
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, DGX could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 2 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on DGX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 56.73 indicates that DGX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.09 indicates that DGX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.36 indicates that DGX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.04 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -11.12 indicates that DGX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term DGX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Quest Diagnostics Inc financial reports and earnings history, Quest Diagnostics Inc (DGX) stock could reach $179.44 by 2030, $300.07 by 2040 and $381.94 by 2050. See the projected annual prices until 2050 of the Quest Diagnostics Inc stock below:
- Quest Diagnostics Inc (DGX) is expected to reach an average price of $239.99 in 2035, with a high prediction of $240.54 and a low estimate of $231.15. This indicates an $36.43% rise from the last recorded price of $175.90.
- Quest Diagnostics Inc (DGX) stock is projected to chart a bullish course in 2040, with an average price target of $290.26, representing an $65.01% surge from its current level. The forecast ranges from a conservative $288.04 to a sky-high $300.07.
- Our analysts predict Quest Diagnostics Inc (DGX) to jump 81.06% by 2045, soaring from $315.16 to an average price of $318.48, potentially reaching $326.36. While $315.16 is the low estimate, the potential upside is significant.
- Quest Diagnostics Inc (DGX) stock is expected to climb by 2050, reaching an average of $380.57, a $116.36% jump from its current level. However, a wide range of estimates exists, with high and low targets of $381.94 and $364.33, respectively, highlighting the market's uncertainty.
Quest Diagnostics Inc Stock (DGX) Year by Year Forecast
Quest Diagnostics Inc Stock (DGX) Price Forecast for 2025
Quest Diagnostics Inc Stock (DGX) is expected to reach an average price of $144.18 in 2025, with a high prediction of $174.00 and a low estimate of $114.37. This indicates an -18.03% fall from the last recorded price of $175.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $152.67 | $146.40 | $166.47 | -13.21% |
| July, 2025 | $150.33 | $149.69 | $165.65 | -14.54% |
| August, 2025 | $158.88 | $145.22 | $161.07 | -9.68% |
| September, 2025 | $167.50 | $160.63 | $174.00 | -4.78% |
| October, 2025 | $151.43 | $146.54 | $167.33 | -13.91% |
| November, 2025 | $157.25 | $149.13 | $160.89 | -10.60% |
| December, 2025 | $165.14 | $152.30 | $173.79 | -6.11% |
Quest Diagnostics Inc Stock (DGX) Price Forecast for 2026
The predicted value for Quest Diagnostics Inc (DGX) in 2026 is set at an average of $181.68. Estimates vary from a peak of $206.07 to a trough of $157.29, indicating an +3.29% surge from the present price of $175.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $168.01 | $161.11 | $172.27 | -4.49% |
| February, 2026 | $163.74 | $162.55 | $170.31 | -6.91% |
| March, 2026 | $168.03 | $160.59 | $171.31 | -4.47% |
| April, 2026 | $163.13 | $162.90 | $178.48 | -7.26% |
| May, 2026 | $169.31 | $157.29 | $170.39 | -3.75% |
| June, 2026 | $170.98 | $167.94 | $176.53 | -2.80% |
| July, 2026 | $179.97 | $170.99 | $187.34 | +2.31% |
| August, 2026 | $172.08 | $170.99 | $181.04 | -2.17% |
| September, 2026 | $180.02 | $171.04 | $180.15 | +2.34% |
| October, 2026 | $191.76 | $178.43 | $193.82 | +9.01% |
| November, 2026 | $198.23 | $191.93 | $198.74 | +12.70% |
| December, 2026 | $190.93 | $190.59 | $206.07 | +8.54% |
Quest Diagnostics Inc Stock (DGX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Quest Diagnostics Inc (DGX) is $196.63, with a high forecast of $220.60 and a low forecast of $172.67. This indicates an +11.79% increase from the last price of $175.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $192.43 | $185.43 | $195.02 | +9.40% |
| February, 2027 | $194.52 | $184.98 | $196.65 | +10.58% |
| March, 2027 | $217.53 | $193.57 | $220.22 | +23.67% |
| April, 2027 | $188.84 | $187.36 | $220.60 | +7.36% |
| May, 2027 | $180.79 | $178.10 | $189.18 | +2.78% |
| June, 2027 | $184.65 | $172.67 | $185.14 | +4.97% |
| July, 2027 | $184.06 | $180.30 | $193.53 | +4.64% |
| August, 2027 | $184.60 | $179.65 | $191.32 | +4.95% |
| September, 2027 | $193.06 | $178.71 | $193.07 | +9.75% |
| October, 2027 | $178.51 | $173.20 | $191.81 | +1.48% |
| November, 2027 | $183.78 | $178.23 | $188.40 | +4.48% |
| December, 2027 | $188.88 | $177.29 | $191.17 | +7.38% |
Quest Diagnostics Inc Stock (DGX) Price Forecast for 2028
In 2028, Quest Diagnostics Inc (DGX) is projected to reach an average price of $188.47, with a high projection of $207.84 and a low estimate of $169.09. This indicates an +7.14% rise from the last price of $175.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $173.67 | $172.82 | $190.85 | -1.27% |
| February, 2028 | $171.43 | $169.09 | $180.45 | -2.54% |
| March, 2028 | $192.65 | $170.89 | $195.85 | +9.52% |
| April, 2028 | $198.26 | $187.09 | $202.27 | +12.71% |
| May, 2028 | $205.77 | $195.44 | $206.08 | +16.98% |
| June, 2028 | $195.09 | $193.93 | $207.84 | +10.91% |
| July, 2028 | $194.67 | $189.69 | $200.39 | +10.67% |
| August, 2028 | $184.43 | $183.33 | $198.83 | +4.85% |
| September, 2028 | $193.21 | $180.51 | $194.11 | +9.84% |
| October, 2028 | $187.04 | $184.83 | $199.10 | +6.34% |
| November, 2028 | $186.35 | $180.13 | $187.00 | +5.94% |
| December, 2028 | $191.55 | $183.13 | $195.33 | +8.90% |
Quest Diagnostics Inc Stock (DGX) Price Forecast for 2029
The 2029 price forecast for Quest Diagnostics Inc Stock (DGX) is $184.09 on average, with a high prediction of $196.78 and a low estimate of $171.40. This represents an +4.66% increase from the previous price of $175.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $186.46 | $183.90 | $196.78 | +6.00% |
| February, 2029 | $183.85 | $182.34 | $189.04 | +4.52% |
| March, 2029 | $177.88 | $177.14 | $186.66 | +1.13% |
| April, 2029 | $174.37 | $171.40 | $178.83 | -0.87% |
| May, 2029 | $184.94 | $172.84 | $187.40 | +5.14% |
| June, 2029 | $188.50 | $183.86 | $189.71 | +7.16% |
| July, 2029 | $190.41 | $186.45 | $194.42 | +8.25% |
| August, 2029 | $181.22 | $180.04 | $196.21 | +3.02% |
| September, 2029 | $180.07 | $175.88 | $183.67 | +2.37% |
| October, 2029 | $182.55 | $176.75 | $184.46 | +3.78% |
| November, 2029 | $181.89 | $178.87 | $188.80 | +3.41% |
| December, 2029 | $176.15 | $173.71 | $196.02 | +0.14% |
Quest Diagnostics Inc Stock (DGX) Price Forecast for 2030
Quest Diagnostics Inc Stock (DGX) is expected to reach an average price of $178.06 in 2030, with a high forecast of $200.59 and a low forecast of $155.53. This signifies an +1.23% surge from the last price of $175.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $178.91 | $172.21 | $179.44 | +1.71% |
| February, 2030 | $181.01 | $177.62 | $182.32 | +2.91% |
| March, 2030 | $179.03 | $176.12 | $182.64 | +1.78% |
| April, 2030 | $181.15 | $175.57 | $182.61 | +2.98% |
| May, 2030 | $186.56 | $180.37 | $187.32 | +6.06% |
| June, 2030 | $180.77 | $179.44 | $187.28 | +2.77% |
| July, 2030 | $186.59 | $180.03 | $186.69 | +6.08% |
| August, 2030 | $187.76 | $185.07 | $189.73 | +6.74% |
| September, 2030 | $187.93 | $184.56 | $188.65 | +6.84% |
| October, 2030 | $194.51 | $186.59 | $194.68 | +10.58% |
| November, 2030 | $177.86 | $170.18 | $200.59 | +1.11% |
| December, 2030 | $156.23 | $155.53 | $173.81 | -11.18% |
2.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):